A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG (Q36347386)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG |
scientific article |
Statements
1 reference
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG (English)
1 reference
S Banerjee
1 reference
G Rustin
1 reference
J Paul
1 reference
C Williams
1 reference
S Pledge
1 reference
H Gabra
1 reference
G Skailes
1 reference
A Lamont
1 reference
A Hindley
1 reference
G Goss
1 reference
E Gilby
1 reference
M Hogg
1 reference
P Harper
1 reference
E Kipps
1 reference
L-A Lewsley
1 reference
M Hall
1 reference
P Vasey
1 reference
S B Kaye
1 reference
5 October 2012
1 reference
1 reference
679-687
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference